COMPASS PATHWAYS PLC Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount
COMPASS PATHWAYS PLC (CMPS) reported Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount of $0 for the 12-month period ending 2024-12-31, per its 10-K filed 2026-03-24.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate · last filed 2026-03-24
- COMPASS PATHWAYS PLC effective income tax rate reconciliation, change in enacted tax rate, amount for fiscal 2024 was $0.00.
- COMPASS PATHWAYS PLC effective income tax rate reconciliation, change in enacted tax rate, amount for fiscal 2023 was -$1.26M.
- COMPASS PATHWAYS PLC effective income tax rate reconciliation, change in enacted tax rate, amount for fiscal 2022 was -$3.61M.
- COMPASS PATHWAYS PLC effective income tax rate reconciliation, change in enacted tax rate, amount for fiscal 2021 was -$10.15M.
| Period end | Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount 12 month |
|---|---|
| 2024-12-31 | $0.00 10-K · filed 2026-03-24 |
| 2023-12-31 | -$1.26M 10-K · filed 2025-02-27 |
| 2022-12-31 | -$3.61M 10-K · filed 2024-02-29 |
| 2021-12-31 | -$10.15M 10-K · filed 2024-02-29 |
| 2020-12-31 | $0.00 10-K · filed 2023-02-28 |
| 2019-12-31 | $0.00 10-K · filed 2022-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ANI PHARMACEUTICALS INC (ANIP) | United States | $1.810B | 18.77 |
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |
| Xencor Inc (XNCR) | United States | $1.776B | -7.33 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |